Israel Charo

Corporate Officer/Principal chez The University of California, San Francisco

74 ans

Consumer Services

Finance

Health Technology

Postes actifs de Israel Charo

Sociétés	Poste	Début	Fin
The University of California, San Francisco	Corporate Officer/Principal	01/01/1991	-

Sociétés	Poste	Début	Fin
CHEMOCENTRYX, INC.	Directeur Technique/Scientifique/R&D	01/09/2014	-
CHEMOCENTRYX, INC.	Corporate Officer/Principal	01/09/2014	-
Bay City Capital LLC Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.	Private Equity Investor	15/12/2010	15/12/2010
	Corporate Officer/Principal	15/12/2010	-

State University of New York at Downstate Medical Center	Doctorate Degree
Stony Brook University	Undergraduate Degree
University of California, Berkeley	Graduate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	3
Private Equity Investor	1
Chief Tech/Sci/R&D Officer	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Bay City Capital LLC Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.	Finance
ChemoCentryx, Inc. ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.	Health Technology

Entreprise privées

Finance

Health Technology